Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
belatacept t-cell-specific surface glycoprotein cd28 NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Heart[MeSHID:D006321]
Kidney[MeSHID:D007668]
Graft Rejection[MeSHID:D006084]		 3.54 approved unknown
belatacept t-lymphocyte activation antigen cd80 biotech NA drugbank , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Heart[MeSHID:D006321]
Kidney[MeSHID:D007668]
Graft Rejection[MeSHID:D006084]		 13.26 approved,investigational antagonist
belatacept t-lymphocyte activation antigen cd80 biotech NA drugbank , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Heart[MeSHID:D006321]
Kidney[MeSHID:D007668]
Graft Rejection[MeSHID:D006084]		 13.26 approved,investigational antagonist,inhibitor
belatacept t-lymphocyte activation antigen cd86 biotech NA drugbank , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Heart[MeSHID:D006321]
Kidney[MeSHID:D007668]
Graft Rejection[MeSHID:D006084]		 12.12 approved,investigational antagonist
belatacept t-lymphocyte activation antigen cd86 biotech NA drugbank , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Heart[MeSHID:D006321]
Kidney[MeSHID:D007668]
Graft Rejection[MeSHID:D006084]		 12.12 approved,investigational antagonist,inhibitor
click here to return to the previous page